Table 4.
Outcomes and complications of surviving patients.
| Surviving patients (n = 57) | Conservative group (n = 15) | Surgical group (n = 42) | p | |
|---|---|---|---|---|
| NIHSS at 6 months | 28 (24–33) | 32 (28–34) | 26 (19–32) | 0.032 |
| GCS at 6 months | 9 (6–14) | 7 (5–11) | 12 (7–15) | 0.043 |
| mRS at 6 months | 0.022 | |||
| 5 | 29 (50.9%) | 11 (73.3%) | 18 (42.9%) | |
| 4 | 18 (31.6%) | 4 (26.7%) | 14 (33.3%) | |
| 3 | 4 (7.0%) | 0 | 4 (9.5%) | |
| 2 | 5 (8.8%) | 0 | 5 (11.9%) | |
| 1 | 1 (1.8%) | 0 | 1 (2.4%) | |
| Complications | ||||
| Central hyperthermia | 20 (35.1%) | 3 (20.0%) | 17 (40.5%) | 0.154 |
| Stress ulcers | 19 (33.3%) | 2 (13.3%) | 17 (40.5%) | 0.056 |
GCS, Glasgow Score Scale; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin scale.